title: Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.
abstract: Propafenone has been shown to affect the delayed-rectifier potassium currents in cardiomyocytes of different animal models. In this study we investigated effects and mechanisms of action of propafenone on HERG potassium channels in oocytes of Xenopus laevis with the two-electrode voltage-clamp technique. Propafenone decreased the currents during voltage steps and the tail currents. The block was voltage-dependent and increased with positive going potentials (from 18% block of tail current amplitude at -40 mV to 69% at +40 mV with 100 micromol/l propafenone). The voltage dependence of block could be fitted with the sum of a monoexponential and a linear function. The fractional electrical distance was estimated to be delta=0.20. The block of current during the voltage step increased with time starting from a level of 83% of the control current. Propafenone accelerated the increase of current during the voltage step as well as the decay of tail currents (time constants of monoexponential fits decreased by 65% for the currents during the voltage step and by 37% for the tail currents with 100 micromol/l propafenone). The threshold concentration of propafenone effect was around 1 micromol/l and the concentration of half-maximal block (IC50) ranged between 13 micromol/l and 15 micromol/l for both current components. With high extracellular potassium concentrations, the IC50 value rose to 80 degrees mol/l. Acidification of the extracellular solution to pH 6.0 increased the IC50 value to 123 micromol/l, alkalization to pH 8.0 reduced it to 10 micromol/l and coexpression of the beta-subunit minK had no statistically significant effect on the concentration dependence. In conclusion, propafenone has been found to block HERG potassium channels. The data suggest that propafenone affects the channels in the open state and give some hints for an intracellular site of action.
authors.affiliation: Institut für Physiologie, Universität Münster, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Mergenthaler
authors.forename: W
authors.initials: W
authors.lastname: Haverkamp
authors.forename: A
authors.initials: A
authors.lastname: Hüttenhofer
authors.forename: B V
authors.initials: BV
authors.lastname: Skryabin
authors.forename: U
authors.initials: U
authors.lastname: Musshoff
authors.forename: M
authors.initials: M
authors.lastname: Borggrefe
authors.forename: E J
authors.initials: EJ
authors.lastname: Speckmann
authors.forename: G
authors.initials: G
authors.lastname: Breithardt
authors.forename: M
authors.initials: M
authors.lastname: Madeja
mesh_terms: D000818:Animals; D027682:Cation Transport Proteins; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D051638:Ether-A-Go-Go Potassium Channels; D006863:Hydrogen-Ion Concentration; D008564:Membrane Potentials / Q000187:drug effects; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000187:drug effects*; D024642:Potassium Channels, Voltage-Gated; D011405:Propafenone / Q000494:pharmacology*; D014982:Xenopus laevis
chemical_list: D027682:Cation Transport Proteins; D051638:Ether-A-Go-Go Potassium Channels; C092509:KCNH6 protein, human; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D011405:Propafenone